Catalog Number 999803845 |
Device Problems
Loose or Intermittent Connection (1371); Loss of Osseointegration (2408); Noise, Audible (3273)
|
Patient Problems
Host-Tissue Reaction (1297); Pain (1994); Inadequate Osseointegration (2646)
|
Event Date 05/15/2014 |
Event Type
Injury
|
Event Description
|
Asr revision; asr resurfacing- right; reason(s) for revision: component (head) loosening, pain, noise, alval.
|
|
Manufacturer Narrative
|
If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.No 510(k) number provided because this implant is sold internationally with different indications for use; it is currently sold in the us under a different part number.The correction/removal reporting number listed applies to the corresponding product code sold domestically.The asr platform was voluntarily recalled from the market in august 2010, and the asr product codes are now considered inactive.Further investigation of this individual incident will not be undertaken, as there is an ongoing investigation regarding the root cause(s) and/or corrective actions.(b)(4).Depuy considers the investigation closed at this time.Should the product and/or additional information be received, the investigation will be re-opened.
|
|
Manufacturer Narrative
|
If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.Depuy still considers this case closed to capa.
|
|
Event Description
|
On sept 2015 - update - rcvd (b)(6) legal, added kid number and marked as legal , added exp dates to products.Patient underwent an operation on (b)(6) 2012 for tissue removal - not implant removal.
|
|
Manufacturer Narrative
|
Product complaint # (b)(4).Investigation summary:the asr platform was voluntarily recalled from the market in august 2010, and the asr product codes are now considered inactive.Further investigation of this individual incident will not be undertaken.The investigation regarding the root cause(s) and/or corrective actions was conducted under mdd capa-(b)(4).Ongoing post market surveillance is conducted per our procedures for this product.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|
|
Search Alerts/Recalls
|